ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) insider James Kihara sold 2,000 shares of ACADIA Pharmaceuticals stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $28.30, for a total transaction of $56,600.00. Following the completion of the transaction, the insider now directly owns 11,025 […]
StockNews.com lowered shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) from a buy rating to a hold rating in a report issued on Thursday. Other analysts have also issued research reports about the stock. Oppenheimer restated a market perform rating and issued a $25.00 price target on shares of ACADIA Pharmaceuticals in a research note […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year target price among brokers […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday. Several other equities analysts also recently commented on ACAD. HC Wainwright reissued a “buy” rating and issued a $33.00 price objective on shares of ACADIA Pharmaceuticals […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) insider James Kihara sold 1,985 shares of ACADIA Pharmaceuticals stock in a transaction on Monday, November 20th. The shares were sold at an average price of $22.64, for a total value of $44,940.40. Following the completion of the transaction, the insider now owns 13,025 shares in the […]